Claus Yding Andersen

Title: Claus Yding Andersen: Innovator in Biologically Active Compounds

Introduction

Claus Yding Andersen is a notable inventor based in Hellerup, Denmark. He has made significant contributions to the field of reproductive medicine through his innovative work on biologically active compounds. His research focuses on enhancing the efficacy of luteinizing hormone (LH) for various medical applications.

Latest Patents

Andersen holds a patent for a long-acting biologically active luteinizing hormone (LH) compound. This invention comprises an LH agonist linked to a pharmaceutically acceptable molecule, which significantly increases the in vivo plasma half-life of the LH agonist compared to traditional methods. The patent outlines methods for controlled ovarian stimulation, which can be utilized in conjunction with assisted reproduction technologies such as in vitro fertilization, intra-cytoplasmic sperm injection, intrauterine insemination, and in vitro maturation. Additionally, the invention includes methods for inducing folliculogenesis and providing luteal support for the corpora lutea.

Career Highlights

Claus Yding Andersen is associated with Arts Biologics A/S, where he continues to advance his research and development efforts. His work has been instrumental in improving reproductive health outcomes through innovative hormonal therapies.

Collaborations

Andersen has collaborated with notable colleagues, including Peter Nordkild and Svend Lindenberg, to further enhance the impact of his research in the field of reproductive medicine.

Conclusion

Claus Yding Andersen's contributions to the development of long-acting biologically active luteinizing hormone compounds represent a significant advancement in reproductive health. His innovative approaches and collaborations continue to pave the way for improved assisted reproduction technologies.